Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

NCT06357754 · clinicaltrials.gov ↗

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukaemia
Multiple Myeloma

Interventions

BIOLOGICAL: Idecabtagene vicleucel
BIOLOGICAL: Lisocabtagene maraleucel

Sponsor

Bristol-Myers Squibb